Cardiotoxicity Associated With Chimeric Antigen Receptor (CAR)-T Cell Therapy for Hematologic Malignancies: A Systematic Review

Chimeric Antigen Receptor (CAR)-T cell therapy has been one of the most important breakthroughs for treating hematologic malignancies. On the other hand, the therapy had many toxicities. One of the toxicities of the CAR-T therapy is cardiotoxicity. The goal of the systematic review is to elaborate o...

Descripción completa

Detalles Bibliográficos
Autores principales: Hanna, Kerollos S, Kaur, Harkirat, Alazzeh, Mohammad S, Thandavaram, Abhay, Channar, Aneeta, Purohit, Ansh, Shrestha, Bijay, Patel, Deepkumar, Shah, Hriday, Mohammed, Lubna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482759/
https://www.ncbi.nlm.nih.gov/pubmed/36148204
http://dx.doi.org/10.7759/cureus.28162

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482759/
https://www.ncbi.nlm.nih.gov/pubmed/36148204
http://dx.doi.org/10.7759/cureus.28162

Ejemplares similares